Literature DB >> 15789441

Interstitial lung disease in patients with ataxia-telangiectasia.

Scott A Schroeder1, Michael Swift, Claudio Sandoval, Claire Langston.   

Abstract

Ataxia-telangiectasia (A-T) is an autosomal-recessive multiorgan disease characterized by progressive neurologic deterioration in which the most common causes of death are diseases of the respiratory system and cancers. The aim of this retrospective study was to delineate the clinical, radiographic, and pathologic manifestations of the chronic progressive interstitial lung disease seen in patients with A-T. The medical records of 97 patients with A-T and chronic lung disease were reviewed. Interstitial lung disease (ILD) was specifically diagnosed in 25 of 97 patients. None of these patients had evidence of an infectious process preceding the onset of their lung disease, and none had lasting clinical improvement after treatment with antibiotics. Although many medications were used to treat their ILD, only treatment with systemic corticosteroids early in the course of their illness was associated with clinical and radiographic improvement. Nineteen of these 25 patients with ILD died within 24 months of the onset of their ILD, and of 7 patients treated with corticosteroids, 5 are still alive. Recognition of interstitial lung disease in patients with A-T and its early treatment could reduce or eliminate pulmonary disease as a leading cause of death for these patients. Copyright 2005 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15789441     DOI: 10.1002/ppul.20209

Source DB:  PubMed          Journal:  Pediatr Pulmonol        ISSN: 1099-0496


  26 in total

1.  Evaluation and management of pulmonary disease in ataxia-telangiectasia.

Authors:  Sharon A McGrath-Morrow; W Adam Gower; Cynthia Rothblum-Oviatt; Alan S Brody; Claire Langston; Leland L Fan; Maureen A Lefton-Greif; Thomas O Crawford; Michelle Troche; John T Sandlund; Paul G Auwaerter; Blaine Easley; Gerald M Loughlin; John L Carroll; Howard M Lederman
Journal:  Pediatr Pulmonol       Date:  2010-09

2.  Exclusion/confirmation of ataxia-telangiectasia via cell-cycle testing.

Authors:  Tilman Heinrich; Carolin Prowald; Richard Friedl; Benni Gottwald; Reinhard Kalb; Kornelia Neveling; Sabine Herterich; Holger Hoehn; Detlev Schindler
Journal:  Eur J Pediatr       Date:  2006-01-13       Impact factor: 3.183

3.  Rapid and progressive pulmonary fibrosis in 2 families with DNA repair deficiencies of undetermined etiology.

Authors:  Timothy J Vece; Marc G Schecter; Richard A Gatti; Rashmi Tunuguntla; Christine Kim Garcia; Claire Langston; Megan K Dishop; Robert H Moore; Leland L Fan
Journal:  J Pediatr       Date:  2012-01-10       Impact factor: 4.406

4.  Ataxia telangiectasia mutated kinase controls chronic gammaherpesvirus infection.

Authors:  Joseph M Kulinski; Steven M Leonardo; Bryan C Mounce; Laurent Malherbe; Stephen B Gauld; Vera L Tarakanova
Journal:  J Virol       Date:  2012-09-19       Impact factor: 5.103

5.  Disturbed B and T cell homeostasis and neogenesis in patients with ataxia telangiectasia.

Authors:  Matan Kraus; Atar Lev; Amos J Simon; Inbal Levran; Andrea Nissenkorn; Yonit B Levi; Yackov Berkun; Ori Efrati; Ninette Amariglio; Gideon Rechavi; Raz Somech
Journal:  J Clin Immunol       Date:  2014-05-01       Impact factor: 8.317

6.  Pilot study of modified LMB-based therapy for children with ataxia-telangiectasia and advanced stage high grade mature B-cell malignancies.

Authors:  J T Sandlund; M M Hudson; W Kennedy; M Onciu; M B Kastan
Journal:  Pediatr Blood Cancer       Date:  2013-07-30       Impact factor: 3.167

Review 7.  Imaging Features of Primary Immunodeficiency Disorders.

Authors:  Jose A Rodriguez; Tami J Bang; Carlos S Restrepo; Daniel B Green; Lorna P Browne; Daniel Vargas
Journal:  Radiol Cardiothorac Imaging       Date:  2021-03-25

8.  Pulmonary function in children and young adults with ataxia telangiectasia.

Authors:  Sharon A McGrath-Morrow; Howard M Lederman; Angela D Aherrera; Maureen A Lefton-Greif; Thomas O Crawford; Timothy Ryan; Jennifer Wright; Joseph M Collaco
Journal:  Pediatr Pulmonol       Date:  2013-02-08

Review 9.  Mechanistic links between aging and lung fibrosis.

Authors:  Victor J Thannickal
Journal:  Biogerontology       Date:  2013-08-09       Impact factor: 4.277

10.  Ataxia-telangiectasia mutated is required for the development of protective immune memory after influenza A virus infection.

Authors:  Rachel Warren; William Domm; Min Yee; Andrew Campbell; Jane Malone; Terry Wright; Margot Mayer-Pröschel; Michael A O'Reilly
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2019-09-11       Impact factor: 5.464

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.